| Literature DB >> 32488017 |
Emre Yağmur Arıcan1, Damla Gökçeoğlu Kayalı2, Bahar Ulus Karaca1, Tuğçe Boran1, Narin Öztürk3, Alper Okyar3, Feriha Ercan2, Gül Özhan4.
Abstract
Acetamiprid, a selective agonist of nicotinic acetylcholine recetors, is one of the most widely used neonicotinoids. There is limited data about toxicity of acetamiprid on male reproductive system. Therefore, the study aimed to investigate the reproductive toxic potential of acetamiprid in male rats orally treated with acetamiprid with low (12.5 mg/kg) medium (25 mg/kg) or high dose (35 mg/kg) for 90 days. According to our results, sperm concentration and plasma testosterone levels decreased in dose dependent manner. Gonadotropin-releasing hormone (GnRH), follicle-stimulating hormeone (FSH), luteinizing hormone (LH) levels increased at low and medium dose groups and acetamiprid caused lipid peroxidation and glutathione (GSH) depletion in the testes. Histologic examinations revealed that acetamiprid induced apoptosis in medium and high dose groups and proliferation index dramatically decreased in high dose group. In conclusion, acetamiprid caused toxicity on male reproductive system in the high dose. The mechanism of the toxic effect may be associated with oxidative stress, hormonal disruptions and apoptosis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32488017 PMCID: PMC7265391 DOI: 10.1038/s41598-020-65887-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Effect of oral acetamiprid on body weights and testicular weights of Sprague Dawley rats.
| Control group (n:10) | Low dose group (n:11) | Medium dose group (n:12) | High dose group (n:12) | |
|---|---|---|---|---|
| Body weights (g) | ||||
| Day 1 | 307.60 ± 1.46 | 329.43 ± 2.65 | 341.93 ± 3.43 | 326.60 ± 2.34 |
| Day 28 | 310.25 ± 1.65 | 326.45 ± 2.98 | 332.74 ± 2.76 | 322.15 ± 1.89 |
| Day 90 | 314.18 ± 1.60 | 322.89 ± 3.55 | 336.46 ± 3.89 | 315.82 ± 2.59 |
| Testicular weights (g) Day 90 | 1.50 ± 0.05 | 1.60 ± 0.03 | 1.55 ± 0.02 | 1.56 ± 0.05 |
Data were shown as mean ± standard error of the means (SEM). *p < 0.05, **p < 0.005, ***p < 0.0005.
Evaluations of sperm morphology and counts in the Sprague Dawley rats treated orally with acetamiprid. Data were shown as mean ± standard error of the means (SEM).
| Sperm count (x106/mL) | ||||
|---|---|---|---|---|
| Control group (n:10) | Low dose group (n:11) | Medium dose group (n:12) | High dose group (n:12) | |
| Sperm count | 12.1 ± 0.4 | 11.4 ± 0.7 | 9.5 ± 0.5** | 8.6 ± 0.4*** |
| Sperm morphology (in 200 sperm) | ||||
| Normal | 173.2 ± 3.8 | 174.0 ± 7.5 | 178.0 ± 3.5 | 163.6 ± 10.0 |
| Headless sperm | 7.3 ± 0.7 | 5.3 ± 1.7 | 5.0 ± 1.3 | 10.6 ± 2.7 |
| Detached head | 13.1 ± 0.7 | 13.6 ± 1.7 | 10.3 ± 1.3 | 15.8 ± 2.7 |
| Flattened head | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.2 ± 0.2 | 3.6 ± 1.2* |
| Pinhead | 0.1 ± 0.1 | 0.3 ± 0.2 | 0.3 ± 0.1 | 0.3 ± 0.2 |
| Bent neck | 2.6 ± 0.3 | 2.7 ± 0.8 | 2.7 ± 0.6 | 3.7 ± 0.7 |
| Bent tail | 1.1 ± 0.2 | 1.2 ± 0.6 | 1.4 ± 0.5 | 1.1 ± 0.3 |
| Coiled tail | 0.7 ± 0.2 | 1.2 ± 0.4 | 0.9 ± 0.6 | 0.9 ± 0.3 |
| Multiple abnomalities | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.4 ± 0.2 |
| Total sperm count with abnormalities | 26.8 ± 3.9 | 26.0 ± 7.5 | 22.0 ± 3.5 | 36.4 ± 10.0 |
| Percentage of the sperm with abnormalities (%) | 13.4 ± 2.0 | 13.0 ± 3.8 | 11.0 ± 1.7 | 18.2 ± 5.0 |
| Percentage of the normal sperm (%) | 86.6 ± 2.0 | 87.0 ± 3.8 | 89.0 ± 1.7 | 81.8 ± 5.0 |
*p < 0.05, **p < 0.005, ***p < 0.0005.
Hormones and oxidative stress parameters at the end of subchronical administration of oral acetamiprid in Sprague Dawley rats.
| Plasma levels (mean ± SEM) | ||||
|---|---|---|---|---|
| Control group (n:10) | Low dose group (n:11) | Medium dose group (n:12) | High dose group (n:12) | |
| Testosteron (ng/mL) | 2.32 ± 0.23 | 1.80 ± 0.49 | 1.65 ± 0.29 | 1.52 ± 0.17 |
| LH (mIU/mL) | 11.07 ± 0.57 | 12.65 ± 0.58* | 13.13 ± 0.17* | 11.86 ± 0.20 |
| FSH (IU/L) | 7.19 ± 0.56 | 11.87 ± 0.38*** | 14.27 ± 0.61*** | 11.30 ± 0.22*** |
| GnRH (ng/L) | 194.89 ± 11.88 | 207.72 ± 7.49 | 209.845 ± 0.95 | 200.67 ± 8.92 |
| INHB (ng/mL) | 8.25 ± 0.28 | 9.18 ± 0.16 | 10.070 ± 0.30* | 7.35 ± 0.53 |
| Cholesterol (mmol/L) | 5.46 ± 0.53 | 4.80 ± 0.34 | 4.39 ± 0.35* | 4.20 ± 0.26* |
| GSH (mmol/mg protein) | 0.47 ± 0.04 | 0.16 ± 0.01** | 0.22 ± 0.01*** | 0.21 ± 0.01*** |
| MDA (ng/mg protein) | 0.56 ± 0.01 | 0.82 ± 0.002*** | 1.03 ± 0.01*** | 1.46 ± 0.06*** |
| TAS (U/mL) | 34.67 ± 2.10 | 16.48 ± 0.78*** | 14.23 ± 0.65*** | 10.24 ± 0.82*** |
| TOS (nmol/mL) | 2.73 ± 0.26 | 2.82 ± 0.09 | 2.97 ± 0.12 | 3.68 ± 0.10*** |
| Tissue levels (mean ± SEM) | ||||
| GSH (mmol/mg protein) | 2.37 ± 0.006 | 1.99 ± 0.12*** | 1.68 ± 0.02*** | 1.52 ± 0.03*** |
| MDA (ng/mg protein) | 6.57 ± 0.46 | 6.87 ± 0.40 | 9.81 ± 1.007* | 11.30 ± 0,52*** |
| TAS (U/mL per g protein) | 46.53 ± 1.61 | 39.63 ± 1.26* | 38.03 ± 1.28*** | 30.54 ± 1.26*** |
| TOS (nmol/mL per g protein) | 12.88 ± 0.03 | 13.28 ± 0.42 | 13.73 ± 0.22 | 14.93 ± 0.20*** |
Data were shown as mean ± standard error of the means (SEM). *p < 0.05, **p < 0.005, ***p < 0.0005. LH: Luteinizing hormone, FSH: Follicle-stimulating hormone, GnRH: Gonadotrophin releasing hormone, INHB: Inhibin B, GSH: Glutathione, MDA: Malondialdehyde, TAS: Total antioxidant status, TOS: Total oxidant status.
Figure 1Representative light micrographs of experimental groups. Normal testis morphology with regular seminiferous tubules are seen in the control group (A). Normal seminiferous tubules (n) with a regular germinal epithelium and vacuolation (arrow) in the low-dose group (B). Some seminiferous tubules with immature cells (*) in their lumen as well as regular seminiferous tubules (n) in the medium-dose group (C); immature cells (*) in the lumen of some seminiferous tubules and vacuolation (arrow, inset) in the germinal epithelium in the high-dose group (D) are seen. H&E staining. Scale bars 50 µm.
Figure 2Representative photomicrographs of experimental groups. The regular basement membran of seminiferous tubules are seen in the control (A) and low-dose groups (B). Irregular and ondulated basement membrane (arrow) of the semniferous tubules are seen in the medium- dose (C) and high-dose groups (D). PAS reaction. Scale bars 50 µm.
Histopathological scoring, proliferation index and apoptotic index in the testes of Sprague Dawley rats treated with oral acetamiprid.
| Control group (n:10) | Low dose group (n:11) | Medium dose group (n:12) | High dose group (n:12) | |
|---|---|---|---|---|
| Seminiferous tubule score | 9.8 | 8.1## | 7.9## | 7.6## |
| Proliferation index | 42.0 | 37.1## | 30.5## | 24.8## |
| Apoptotic index (%) | 0 | 10.6 | 26.3# | 57.5## |
*p < 0.05, #p < 0.1, ##p < 0.01.
Figure 3Representative photomicrographs of PCNA stained testis tissues of the experimental groups. PCNA-positive cells (arrow), numerous in the control (A) and low (B)-dose groups, moderately decreased in the medium (C)-dose group, and severely decreased in the high (D)-dose group, are observed. Scale bars 50 µm.
Figure 4Representative photomicrographs of TUNEL stained testis tissues of the experimental groups. A few number of TUNEL-positive cells (arrow), in the control (A) and low (B)-dose groups, moderately increased in the medium (C)-dose group, and severely increased in the high (D)-dose group are observed. TUNEL. Scale bars 50 µm.
Modified Johnson Scoring Method[22].
| Score | Histological Findings |
|---|---|
| 10 | Full spermatogenesis |
| 9 | Slightly impaired spermatogenesis, many late spermatids, disorganized epithelium |
| 8 | Less than five spermatozoa per tubule, few late spermatids |
| 7 | No spermatozoa, no late spermatids, many early spermatids |
| 6 | No spermatozoa, no late spermatids, few early spermatids |
| 5 | No spermatozoa or spermatids, many spermatocytes |
| 4 | No spermatozoa or spermatids, few spermatocytes |
| 3 | Spermatogonia only |
| 2 | No germinal cells, Sertoli cells only |
| 1 | No seminiferous epithelium |